Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 Substituted Furanoside. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1066658A details efficient asymmetric synthesis of antiviral furanoside intermediates, offering scalable routes for HIV therapeutic manufacturing.